Bayer CropScience Ltd
Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]
- Market Cap ₹ 19,753 Cr.
- Current Price ₹ 4,398
- High / Low ₹ 6,540 / 4,217
- Stock P/E 401
- Book Value ₹ 84.5
- Dividend Yield 2.84 %
- ROCE 20.1 %
- ROE 15.8 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 52.0 times its book value
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.83.7 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Dec 2005 | Dec 2006 | |
|---|---|---|
| 223 | 242 | |
| 194 | 225 | |
| Operating Profit | 29 | 18 |
| OPM % | 13% | 7% |
| 7 | 18 | |
| Interest | 2 | 3 |
| Depreciation | 6 | 6 |
| Profit before tax | 27 | 27 |
| Tax % | 71% | 36% |
| 8 | 17 | |
| EPS in Rs | 1.97 | 4.37 |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Dec 2005 | Dec 2006 | |
|---|---|---|
| 667 | 727 | |
| 610 | 692 | |
| Operating Profit | 57 | 35 |
| OPM % | 9% | 5% |
| 50 | 84 | |
| Interest | 8 | 9 |
| Depreciation | 23 | 23 |
| Profit before tax | 77 | 87 |
| Tax % | 50% | 36% |
| 38 | 55 | |
| EPS in Rs | 9.71 | 14.03 |
| Dividend Payout % | 23% | 17% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -3% |
| 3 Years: | 0% |
| 1 Year: | -14% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 16% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Dec 2005 | Dec 2006 | |
|---|---|---|
| Equity Capital | 40 | 40 |
| Reserves | 250 | 294 |
| 120 | 112 | |
| 436 | 468 | |
| Total Liabilities | 846 | 914 |
| 161 | 153 | |
| CWIP | 8 | 4 |
| Investments | 4 | 4 |
| 674 | 754 | |
| Total Assets | 846 | 914 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Dec 2005 | Dec 2006 | |
|---|---|---|
| -12 | 38 | |
| -34 | -16 | |
| 25 | -26 | |
| Net Cash Flow | -21 | -4 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Dec 2005 | Dec 2006 | |
|---|---|---|
| Debtor Days | 94 | 108 |
| Inventory Days | 186 | 163 |
| Days Payable | 170 | 139 |
| Cash Conversion Cycle | 111 | 133 |
| Working Capital Days | 112 | 128 |
| ROCE % | 20% |
Documents
Announcements
-
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR), Regulations, 2015.
27 Jan - Board meeting Feb 11, 2026 to approve unaudited Q3 results for quarter ended Dec 31, 2025.
-
Update To The Disclosure Made Pursuant To Regulation 30 Of The SEBI (LODR) Regulations, 2015
22 Jan - CESAT set aside Rs100 million penalty; ~INR13 million export-incentive demand quashed (order Jan 20, 2026).
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
7 Jan - Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended December 31, 2025.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
29 Dec 2025 - Newspaper publication regarding the special window for re-lodgement of transfer requests for physical shares.
-
Disclosure Pursuant To Regulation 30 Of The SEBI (LODR) Regulations, 2015
25 Dec 2025 - Penalty orders: Rs.1M (FY2018-19) and Rs.103M (FY2019-20); received Dec 24, 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Nov 2025Transcript PPT
-
Aug 2024Transcript PPT
-
Jun 2023Transcript PPT
-
Jun 2022Transcript PPT
-
Nov 2021Transcript PPT
-
May 2021TranscriptAI SummaryPPT
-
Nov 2020TranscriptAI SummaryPPT
-
May 2020TranscriptAI SummaryPPT
-
Nov 2019TranscriptAI SummaryPPT
-
May 2019TranscriptAI SummaryPPT
-
Nov 2018TranscriptAI SummaryPPT
-
Jun 2018TranscriptAI SummaryPPT
-
Aug 2017TranscriptAI SummaryPPT
-
Feb 2017TranscriptAI SummaryPPT
-
Jul 2016TranscriptAI SummaryPPT
-
Nov 2015TranscriptAI SummaryPPT
History[1]
The Bayer group launched its Indian operations in 1958 by setting up an agrochemical manufacturing unit, in which the group has 68.58% stake. Company manufactures and markets crop protection solutions, and trades in seeds on behalf of Bayer Bioscience Pvt Ltd.